在人体肝脏微粒体中VX代谢的体外表征和救援
Thomas R Lane1, David Koebel1, Eric Lucas1
1Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina (T.R.L., S.E.) and Battelle Memorial Institute, Columbus, Ohio (D.K., E.L., R.M.).
概括
人类中毒剂X (VX) 代谢的理解很少. 这项研究确定了乙烯基二胺三酸 (EDTA) 是增强人肝显微体中的VX代谢,这表明了对VX中毒的潜在新疗法.
科学领域:
- 生物化学 生物化学
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 毒剂X (VX) 是一种高度有毒的有机酸乙胆化酶 (AChE) 抑制剂.
- 人类对VX的新陈代谢尚不清楚,单个中毒病例的数据有限.
- 实验室研究表明,对于已知的VX代谢酶,其生理相关性有限.
研究的目的:
- 为了描述人肝显微体 (HLM) 中VX的体外代谢.
- 为了确定增强VX代谢的潜在因素或化合物.
- 探索VX在常见的生物缓冲区中的稳定性.
主要方法:
- 用HLM化VX以评估代谢.
- 识别VX代谢物.
- 测试乙烯基二胺三酸 (EDTA) 对VX代谢速率的影响.
- 在各种缓冲中分析VX稳定性.
主要成果:
- HLM化显著增加了VX代谢,这表明细胞染色体P450的参与.
- 观察到一种具有两种不同的代谢速率的双相衰变模式.
- 乙烯基二胺四酸 (EDTA) 被确定为增强VX代谢的速度.
- 在共同的生物缓冲区之间发现了VX稳定性的显著差异.
结论:
- 人类肝脏微粒调解VX的新陈代谢,涉及的途径超出了简单的水解.
- 乙烯二胺四酸 (EDTA) 增强了VX代谢,提供了一个潜在的治疗策略.
- 了解缓冲器中的VX稳定性对于准确的实验设计和解释至关重要.
相关概念视频
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...


